08/01/2025 6:12 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/22/2025 7:25 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2025 7:26 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2025 7:27 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2025 7:29 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/21/2025 6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2025 7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2025 6:00 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2025 6:01 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2025 6:02 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2025 6:03 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/02/2025 6:10 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/27/2025 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2025 8:00 AM | BioXcel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025 6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2025 6:23 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 3:16 PM | BioXcel Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2025 3:32 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2025 3:30 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:06 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:07 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 4:00 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2025 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/17/2025 5:35 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:36 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:37 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:38 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:21 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:51 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
03/03/2025 7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:27 PM | ARMISTICE CAPITAL, LLC (Filed by) BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 4:28 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/20/2025 11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025 7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
One stock to replace Nvidia (Ad) I'm a Futurist: Here are 3 stocks better than Nvidia
Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas. Click here for complete analysis. |
01/16/2025 7:03 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/16/2025 7:04 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:00 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:01 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:03 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/08/2025 6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024 7:19 PM | BioXcel Therapeutics (Subject) Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024 4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024 4:20 PM | BioXcel Therapeutics (Subject) Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024 5:10 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:03 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:06 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:21 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 2:33 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024 2:23 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 2:00 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 1:10 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 3:05 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/25/2024 3:06 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024 3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024 8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 8:53 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:33 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:40 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:17 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 6:17 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024 6:18 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:19 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:20 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:23 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 4:42 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:26 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:16 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 2:48 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 1:58 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (Ad) Trump's Radical New Plan Could Enrich Thousands
This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline. Click here to see the full story. |
09/16/2024 12:23 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 9:47 AM | BioXcel Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |